FindTrial
Sign In

comparison of fentanyl, fentanyl- dexmedetomidine and dexmedetomidine in combination with 0.5% hyperbaric bupivacaine as intrathecal adjuvants for lower limb orthopedic surgeries

Comparative study of efficacy of intra thecal fentanyl, dexmedetomidine and fentanyl-dexmedetomidine combination as adjuvants to 0.5% hyperbaric bupivacaine for lower limb orthopaedic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/037937
Enrollment
84
Registered
2021-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

Intervention1: dexmedetomidine: Group BD: In this group â?? 28 patients will be studied and will receive 0.5% hyperbaric bupivacaine 12.5mg [2.5ml] plus dexmedetomidine 10mcg(0.1ml) plus 0.4ml normal

Sponsors

Yenepoya medical college hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Weight-50-80kgs Height-150-180cms ASA grade 1 and 2

Exclusion criteria

Exclusion criteria: Patients undergoing emergency surgery Cardiovascular diseases Patients with coagulopathy Known contra indication for spinal anaesthesia and drugs-fentanyl, dexmedetomidine and bupivacaine Pregnant women Psychiatric disorders

Design outcomes

Primary

MeasureTime frame
Reduced adverse effects and longer duration of post operative analgesiaTimepoint: outcome will be assessed at the end of 24-48 hours—

Secondary

MeasureTime frame
Hemodynamic stability of the drugsTimepoint: Within 48 hours—

Countries

India

Contacts

Public ContactFaarisaA

Yenepoya medical college hospital

drbhatta77@yahoo.co.in9449568734

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026